Fractional CO2 laser therapy has emerged as a promising treatment for various gynecological conditions, particularly for improving vaginal health in women experiencing issues such as vaginal relaxation syndrome and recurrent bacterial vaginitis. Recent studies have indicated that this therapy can significantly enhance the vaginal microbiota, particularly by increasing the population of beneficial Lactobacillus species, which are crucial for maintaining a healthy vaginal environment.
Despite the positive outcomes associated with fractional CO2 laser therapy, there are concerns regarding the long-term effects on vaginal microbiota. While the immediate effects appear beneficial, the potential for dysbiosis—an imbalance in the microbial community—remains a critical area for further research. Dysbiosis can lead to various complications, including increased susceptibility to infections and other vaginal health issues.
In summary, fractional CO2 laser therapy shows promise in enhancing vaginal microbiota and overall vaginal health, particularly through the promotion of Lactobacillus species and improved vaginal pH levels. However, ongoing research is essential to fully understand the long-term implications of this therapy on vaginal microbiota balance and to ensure that it does not inadvertently lead to dysbiosis or other adverse effects.